Kanghui Pharmaceutical announced that Kanghui Holdings, a shareholder holding more than 5% of the shares, and Wang Yanling, a co-actor, will register some of their shares as pledges. Kanghui Holdings holds 147.326 million shares of the company, accounting for 14.75% of the total share capital. This time, it pledged 5 million shares, accounting for 33.94% of its shares; Wang Yanling held 6.65 million shares, accounting for 6.66%, and pledged 5 million shares, accounting for 75.19% of its shares. The two held a total of 21.3826 million shares of the company, accounting for 21.4%. After the pledge was completed, they pledged a total of 10 million shares, accounting for 46.77% of the total number of shares held by both parties, accounting for 10.01% of the company's total share capital. Pledged financing funds are used to supplement working capital.

Kanghui Pharmaceutical announced that Kanghui Holdings, a shareholder holding more than 5% of the shares, and Wang Yanling, a co-actor, will register some of their shares as pledges. Kanghui Holdings holds 147.326 million shares of the company, accounting for 14.75% of the total share capital. This time, it pledged 5 million shares, accounting for 33.94% of its shares; Wang Yanling held 6.65 million shares, accounting for 6.66%, and pledged 5 million shares, accounting for 75.19% of its shares. The two held a total of 21.3826 million shares of the company, accounting for 21.4%. After the pledge was completed, they pledged a total of 10 million shares, accounting for 46.77% of the total number of shares held by both parties, accounting for 10.01% of the company's total share capital. Pledged financing funds are used to supplement working capital.